MIGAL Accelerates COVID-19 Vaccine Development

Source: Dassault Systèmes Americas

When COVID-19 became a pandemic, scientists at the Migal Galilee Research Institute in Israel – an academic research and development center – began using applications and computational tools to apply its research to the study of COVID-19 mutations. Watch the video to learn how they used these tools to accelerate their research and development of a possible vaccine against SARS-CoV-2. 


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online

Dassault Systèmes Americas